CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax of $727.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax · last filed 2026-07-29
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for the quarter ending 2026-06-30 was $727.00K.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for the quarter ending 2025-12-31 was $42.00K, a 97.64% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for the quarter ending 2025-09-30 was -$541.00K, a 301.87% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for the quarter ending 2025-06-30 was -$900.00K, a 145.57% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2025 was -$234.00K, a 104.33% decline from fiscal 2024.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2024 was $5.41M, a 37.31% decline from fiscal 2023.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2023 was $8.63M, a 46.14% decline from fiscal 2022.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2022 was $16.02M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $727.00K 10-Q · filed 2026-07-29 | $646.00K 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$499.00K derived: sum of 2 quarters · filed 2026-02-17 | -$1.40M derived: sum of 3 quarters · filed 2026-07-29 | -$234.00K 10-K · filed 2026-02-17 |
| 2025-09-30 | -$541.00K 10-Q · filed 2025-11-06 | -$1.44M derived: sum of 2 quarters · filed 2026-07-29 | -$276.00K 10-Q · filed 2025-11-06 | $1.50M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$900.00K 10-Q · filed 2026-07-29 | $266.00K 10-Q · filed 2026-07-29 | $2.04M derived: sum of 3 quarters · filed 2026-07-29 | $2.31M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $1.17M 10-Q · filed 2025-05-01 | $2.94M derived: sum of 2 quarters · filed 2026-02-17 | $3.21M derived: sum of 3 quarters · filed 2026-02-17 | $5.19M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.05M derived: sum of 2 quarters · filed 2026-02-17 | $4.02M derived: sum of 3 quarters · filed 2026-02-17 | $5.41M 10-K · filed 2026-02-17 |
| 2024-09-30 | $268.00K 10-Q · filed 2025-11-06 | $2.24M derived: sum of 2 quarters · filed 2025-11-06 | $3.63M 10-Q · filed 2025-11-06 | $6.21M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $1.98M 10-Q · filed 2025-07-31 | $3.36M 10-Q · filed 2025-07-31 | $5.94M derived: sum of 3 quarters · filed 2026-02-17 | $8.52M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.39M 10-Q · filed 2025-05-01 | $3.97M derived: sum of 2 quarters · filed 2026-02-17 | $6.55M derived: sum of 3 quarters · filed 2026-02-17 | $8.64M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $5.16M derived: sum of 2 quarters · filed 2026-02-17 | $7.25M derived: sum of 3 quarters · filed 2026-02-17 | $8.63M 10-K · filed 2026-02-17 |
| 2023-09-30 | $2.58M 10-Q · filed 2024-10-31 | $4.67M derived: sum of 2 quarters · filed 2024-10-31 | $6.05M 10-Q · filed 2024-10-31 | $11.34M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $2.09M 10-Q · filed 2024-08-01 | $3.47M 10-Q · filed 2024-08-01 | $8.76M derived: sum of 3 quarters · filed 2025-02-18 | $14.07M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.38M 10-Q · filed 2024-04-25 | $6.67M derived: sum of 2 quarters · filed 2025-02-18 | $11.98M derived: sum of 3 quarters · filed 2025-02-18 | $15.59M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $10.60M derived: sum of 2 quarters · filed 2025-02-18 | $14.21M derived: sum of 3 quarters · filed 2025-02-18 | $16.02M 10-K · filed 2025-02-18 |
| 2022-09-30 | $5.32M 10-Q · filed 2023-10-26 | $8.92M derived: sum of 2 quarters · filed 2023-10-26 | $10.74M 10-Q · filed 2023-10-26 | $10.58M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $3.60M 10-Q · filed 2023-07-27 | $5.42M 10-Q · filed 2023-07-27 | $5.26M derived: sum of 3 quarters · filed 2024-02-28 | $4.61M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.82M 10-Q · filed 2023-04-27 | $1.66M derived: sum of 2 quarters · filed 2024-02-28 | $1.00M derived: sum of 3 quarters · filed 2024-02-28 | -$607.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$814.00K derived: sum of 2 quarters · filed 2024-02-28 | -$2.43M derived: sum of 3 quarters · filed 2024-02-28 | -$4.01M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$658.00K 10-Q · filed 2022-10-27 | -$2.27M derived: sum of 2 quarters · filed 2022-10-27 | -$3.85M 10-Q · filed 2022-10-27 | -$3.97M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | -$1.61M 10-Q · filed 2022-07-28 | -$3.20M 10-Q · filed 2022-07-28 | -$3.31M derived: sum of 3 quarters · filed 2023-02-21 | -$2.87M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | -$1.58M 10-Q · filed 2022-05-05 | -$1.70M derived: sum of 2 quarters · filed 2023-02-21 | -$1.25M derived: sum of 3 quarters · filed 2023-02-21 | -$1.33M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $330.00K derived: sum of 2 quarters · filed 2023-02-21 | $254.00K derived: sum of 3 quarters · filed 2023-02-21 | $1.38M 10-K · filed 2023-02-21 |
| 2020-09-30 | $448.00K 10-Q · filed 2021-10-28 | $372.00K derived: sum of 2 quarters · filed 2021-10-28 | $1.50M 10-Q · filed 2021-10-28 | $3.91M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$76.00K 10-Q · filed 2021-07-29 | $1.05M 10-Q · filed 2021-07-29 | $3.46M derived: sum of 3 quarters · filed 2022-02-22 | $5.82M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $1.12M 10-Q · filed 2021-04-29 | $3.54M derived: sum of 2 quarters · filed 2022-02-22 | $5.90M derived: sum of 3 quarters · filed 2022-02-22 | $8.13M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $4.78M derived: sum of 2 quarters · filed 2022-02-22 | $7.01M derived: sum of 3 quarters · filed 2022-02-22 | $8.61M 10-K · filed 2022-02-22 |
| 2019-09-30 | $2.36M 10-Q · filed 2020-10-29 | $4.59M derived: sum of 2 quarters · filed 2020-10-29 | $6.19M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $2.23M 10-Q · filed 2020-07-30 | $3.83M 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $1.60M 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | -$913.00K 10-K · filed 2021-02-22 | |||
| 2017-12-31 | -$718.00K 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |